framycetin has been researched along with Graft-Versus-Host Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahn, JY; Certoux, JM; Deconinck, E; Deschamps, M; Ferrand, C; Lioure, B; Mercier-Letondal, P; Milpied, N; Robinet, E; Sauce, D; Tiberghien, P | 1 |
| Lundskog, B; Nylander, E; Wahlin, A; Wahlin, YB | 1 |
| Brenner, MK; Heslop, HE; Krance, RA; Moen, R; Roberts, WM; Rochester, R; Rooney, C; Sixbey, J; Smith, CA; Turner, V | 1 |
| Ball, LM; Fairclough, S; Martin, J; Rhodes, LE; van Saene, HK; White, S | 1 |
| Bonini, C; Bordignon, C; Ciceri, F; Marktel, S; Nobili, N; Traversari, C; Verzeletti, S | 1 |
| Certoux, JM; Chalmers, D; Contassot, E; Ferrand, C; Hervé, P; Maddens, S; Otto, E; Tiberghien, P | 1 |
| Keast, D | 1 |
| Keast, D; Walters, MN | 1 |
1 trial(s) available for framycetin and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.
Topics: Adult; Biomarkers; Bone Marrow Transplantation; Cell Line; Child; Clinical Protocols; Cytotoxicity, Immunologic; Drug Resistance; Female; Genetic Vectors; Graft vs Host Disease; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Incidence; Informed Consent; Kanamycin Kinase; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Moloney murine leukemia virus; Myelodysplastic Syndromes; Neomycin; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Safety; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation, Homologous; Tumor Virus Infections; Virus Activation | 1994 |
7 other study(ies) available for framycetin and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?
Topics: Adult; Amino Acid Sequence; Bone Marrow Transplantation; Cytomegalovirus; Cytotoxicity, Immunologic; Genetic Vectors; Graft vs Host Disease; Herpesvirus 4, Human; Humans; In Vitro Techniques; Lymphocyte Count; Lymphocyte Depletion; Middle Aged; Neomycin; Retroviridae; Simplexvirus; T-Lymphocytes; Thymidine Kinase; Transduction, Genetic; Transplantation, Homologous; Viral Proteins | 2008 |
Genital graft-versus-host disease in a male following allogeneic stem cell transplantation.
Topics: Anti-Bacterial Agents; Betamethasone; Chronic Disease; Glucocorticoids; Graft vs Host Disease; Humans; Male; Middle Aged; Neomycin; Penile Diseases; Stem Cell Transplantation; Transplantation, Homologous | 2007 |
Microbial carriage, sepsis, infection and acute GVHD in the first 25 BMT at the Royal Liverpool Children's Hospital.
Topics: Adolescent; Bone Marrow Transplantation; Carrier State; Child; Child, Preschool; Chlorhexidine; Colistin; Digestive System; Disease Susceptibility; Drug Therapy, Combination; England; Female; Graft vs Host Disease; Humans; Incidence; Infant; Male; Neomycin; Neutropenia; Nystatin; Premedication; Retrospective Studies; Sepsis; Survival Analysis | 1993 |
Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors.
Topics: Anti-Bacterial Agents; Antiviral Agents; Blotting, Southern; Drug Resistance, Microbial; Flow Cytometry; Ganciclovir; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Lymphocyte Activation; Lymphocytes; Neomycin; Proviruses; Retroviridae; Simplexvirus; Thymidine Kinase | 1998 |
Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trial.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; DNA, Recombinant; Drug Resistance, Microbial; Genetic Therapy; Graft vs Host Disease; Humans; Mice; Neomycin; Polymerase Chain Reaction; Reference Standards; Sensitivity and Specificity; Simplexvirus; Spleen; T-Lymphocytes; Thymidine Kinase; Transfection; Transplantation, Homologous; Transplantation, Isogeneic | 2000 |
A simple index for the measurement of the runting syndrome and its use in the study of the influence of the gut flora in its production.
Topics: Animals; Animals, Newborn; Bacterial Vaccines; Body Weight; Cortisone; Endotoxins; Graft vs Host Disease; Intestines; Intubation, Gastrointestinal; Mice; Neomycin; Reoviridae Infections; Thymectomy; Transplantation Immunology | 1968 |
The pathology of murine runting and its modification by neomycin sulphate gavages.
Topics: Animals; Animals, Newborn; Antigen-Antibody Reactions; Bacterial Vaccines; Cortisone; Endotoxins; Graft vs Host Disease; Intubation, Gastrointestinal; Mice; Neomycin; Reoviridae Infections; Thymectomy; Transplantation Immunology | 1968 |